np event 2254995 0E193A 1
Nov 6, 2025
- Nov 5, 2026
AANEM 2025: Conference Review and Analysis for New Data on Emerging BAFF/APRIL Inhibitors for the Management of Patients with Generalized Myasthenia Gravis
1.0

Claim your AMA PRA Category 1 Credit(s), CNE Contact Hour(s) or CPE Contact Hour(s) (CEUs)

Login to take this course.

This course is available for logged in users only. Please login or register to take the course.

Related Courses

np document 888746 0E193A 5
Pulmonology
Management of Patients with Non-Cystic Fibrosis Bronchiectasis: Reducing Burden of Disease...
np document 888746 0E193A 5
Neurology
The Role of Complement Pathway Inhibitors in the Management of Chronic Inflammatory Demyel...
np document 888746 0E193A 5
Cardiology
Will We See a New Paradigm for SPAF? Which Patients Are More Likely to Benefit from FXIa I...